Bolar Pharmaceuticals / Syntax / Delta Period / Merck / Joseph Steller co / Boston Consulting Group / Bristol-Myers Squibb / /
Continent
America / Europe / /
Country
Japan / United States / /
Event
FDA Phase / /
IndustryTerm
pharmaceutical industry / generic product / abbreviated new drug applications / chemical demonstrating / generic manufacturer / pharmaceuticals / healthcare system / research-based pharmaceutical industry / Foreign patent applications / generic products / law / pioneer products / /
Organization
House Rules Committee / Antitrust Division / Food and Drug Administration / Reagan Administration / Cabinet Council / House of Representatives / U.S. Patent and Trademark Office / U.S. Department of Commerce / Cabinet Council on Commerce and Trade / World Trade Organization / Reagan's Cabinet Council on Commerce and Trade / Pharmaceutical Manufacturers Association / Senate / U.S. Court of Appeals / U.S. Department of Justice / UN Court / US Federal Reserve / Carter's Administration / Health Subcommittee / /
Person
Bruce Lehman / Bill Baxter / David Kessler / David Pryor / William C. Cray / Henry A. Waxman / Malcolm Baldridge / Carter / Gerald J. Mossinghoff / Charles W. Johnson / Reagan / Roger E. Schecter / Estes Kefauver / John Chafee / Washington Legal Found / /
Position
Counsel / President / Chairman / Assistant Secretary / Commissioner / author / the committee / Secretary of Commerce / Commissioner of Patents and Trademarks / /
Overview of the Hatch-Waxman Act and Its Impact on the Drug Development Process